Previous 10 | Next 10 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at th...
Twist Bioscience ( NASDAQ: TWST ), a developer of synthetic DNA-based products and its partner Biotia, Inc. announced on Tuesday that the FDA authorized their product, SARS-CoV-2 Next-Generation Sequencing Assay for the detection of COVID variants and specific gene mutations. ...
Zone of potential insufficiency, where storage demand outstrips capacity, could be >25 zettabytes during 2030 Approximately 75% of all data stored to be ‘cold’ data, infrequently accessed ‘just in case’ it is needed Data retention times are ‘...
- FDA EUA Variant Calling Assay Allows for Sequencing to Inform Patient Treatment - Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF (NYSEARCA: ARKK ), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 third quarter ended June 30, 2022, before the ...
ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter. Coinbase Global, Roku, Shopify, and Ginkgo Bioworks were increased while decreasing Spotify, Ionis Pharma, Vertex Pharma, and Sea Limited. The top three positions are Tesla, Zoom Video, and Rok...
Twist Bioscience ( NASDAQ: TWST ) said on Thursday it launched two human monkeypox virus synthetic DNA controls. ( TWST ) stock rose ~4% before the bell. The monkeypox synthetic DNA controls are designed based on specific monkeypox clades, cover over 80% o...
New synthetic controls add to growing portfolio of NGS applications for viral diseases Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched two ...
Twist Biosciences ( NASDAQ: TWST ) has entered into a collaboration with DNAnexus to develop next-generation sequencing-based diagnostic tests . The agreement allows Twist ( TWST ) customers to use the company's NGS Methylation Detection System and Unique Molecular...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...